- Oral presentation
- Open Access
The use of implantable cardioverter defibrillators in pediatric patients
© Campagnucci et al; licensee BioMed Central Ltd. 2013
- Published: 11 September 2013
- Pediatric Patient
- Congenital Heart Disease
- Congenital Heart
- Sudden Death
The implant of devices in children is always a challenge. Implantable Cardioverter Defibrillator (ICD) therapy has been indicated to 14 children from March 2003 to June 2012 at Santa Casa de Sao Paulo Hospital. Ages ranged between 8 and 16 year old. The objective of this study was to analyze all pathologies, techniques, medical treatment and events related to these children.
The following diagnoses were observed: Long QT syndrome (n=2), Hypertrophic cardiomyopathy (n=3), Brugada syndrome (n=1), LV Noncompaction (n=1), Congenital Heart Disease – postoperative (n=3), Dilated Cardiomyopathy (n=1), Catecholaminergic ventricular tachycardia (n=1), Rhythmogenic right ventricular tachycardia (n=1) and Idiopathic VT (n=1). Syncope (n=4), Ventricular Tachycardia (n=6), or recovery from sudden death (n=4) was the indication for ICD.
In all cases an endovascular endocardial approach for implanting ICDs was used. The prostheses were located below the left pectoralis major muscle, in 12 patients and below the rectus abdominis muscle in two patients. The defibrillation threshold has been distributed as follows: 15J (n=1), 20J (n=11), and 36J (n=2).
The children have been followed from one month to nine years. Each patient received pharmacological treatment for the arrhythmias with specific drugs. Seven patients had no events. Inappropriate shocks occurred in six patients. Three of them needed ablation due to atrial tachycardia. One patient had appropriate shocks. Two patients had lead dysfunction and needed replacement.
cardioverter defibrillator implantation was successfully done by endovascular approach in our pediatric patients. The follow-up of this group has showed that ICDs are the solution for those children with tachyarrhythmia whose medical treatment failed.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.